ES2147163B1 - Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion. - Google Patents
Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion.Info
- Publication number
- ES2147163B1 ES2147163B1 ES009900182A ES9900182A ES2147163B1 ES 2147163 B1 ES2147163 B1 ES 2147163B1 ES 009900182 A ES009900182 A ES 009900182A ES 9900182 A ES9900182 A ES 9900182A ES 2147163 B1 ES2147163 B1 ES 2147163B1
- Authority
- ES
- Spain
- Prior art keywords
- pharmaceutical composition
- expression
- adhesion molecules
- regulatory activity
- soluble extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Una composición farmacéutica con actividad reguladora de la expresión de las moléculas de adhesión y poblaciones linfocitarias y su aplicación como agente antiinflamatorio.Esta composición farmacéutica contiene como principio activo el Anapsos, un extracto hidrosoluble y un extracto liposoluble de los rizomas de Polypodium, junto con excipientes aceptables.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009900182A ES2147163B1 (es) | 1999-01-25 | 1999-01-25 | Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion. |
EP00901148A EP1172111A1 (en) | 1999-01-25 | 2000-01-21 | Pharmaceutical composition with adhesion molecule expression regulating activity |
US09/889,846 US6706293B1 (en) | 1999-01-25 | 2000-01-21 | Pharmaceutical composition capable of regulating the expression of adhesion molecules |
JP2000594476A JP2002535281A (ja) | 1999-01-25 | 2000-01-21 | 接着分子の発現を調節することができる薬剤組成物 |
PCT/ES2000/000026 WO2000043023A1 (es) | 1999-01-25 | 2000-01-21 | Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009900182A ES2147163B1 (es) | 1999-01-25 | 1999-01-25 | Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2147163A1 ES2147163A1 (es) | 2000-08-16 |
ES2147163B1 true ES2147163B1 (es) | 2001-03-01 |
Family
ID=8307118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES009900182A Expired - Fee Related ES2147163B1 (es) | 1999-01-25 | 1999-01-25 | Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion. |
Country Status (5)
Country | Link |
---|---|
US (1) | US6706293B1 (es) |
EP (1) | EP1172111A1 (es) |
JP (1) | JP2002535281A (es) |
ES (1) | ES2147163B1 (es) |
WO (1) | WO2000043023A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2876032B1 (fr) * | 2004-10-05 | 2008-10-31 | Greentech Sa Sa | Utilisation d'extraits de fougeres dans des preparations cosmetiques ou dermatologiques |
CN100431581C (zh) * | 2006-01-20 | 2008-11-12 | 丽珠医药集团股份有限公司 | 治疗禽流感的中药组合物、制备方法及其用途 |
EP2625264B1 (en) | 2010-10-08 | 2022-12-07 | Terumo BCT, Inc. | Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions |
WO2015073913A1 (en) | 2013-11-16 | 2015-05-21 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
US11008547B2 (en) | 2014-03-25 | 2021-05-18 | Terumo Bct, Inc. | Passive replacement of media |
US20160090569A1 (en) | 2014-09-26 | 2016-03-31 | Terumo Bct, Inc. | Scheduled Feed |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
EP3464565A4 (en) | 2016-05-25 | 2020-01-01 | Terumo BCT, Inc. | CELL EXPANSION |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
US11629332B2 (en) | 2017-03-31 | 2023-04-18 | Terumo Bct, Inc. | Cell expansion |
US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0503208A1 (en) * | 1991-03-08 | 1992-09-16 | Maracuyama International, S.A. | Procedure for obtaining a natural water-soluble extract from the leaves and/or rhizomes of various immunologically active ferns |
PT680762E (pt) * | 1994-05-06 | 2002-12-31 | Esp Farmaceuticas Centrum Sa | Composicao farmaceutica compreendendo extracto(s) de feito para tratamento de disfuncoes neurodegenerativas |
AU4152297A (en) * | 1996-08-21 | 1998-03-06 | American Home Products Corporation | Beta2 integrin cell adhesion molecule inhibitors |
-
1999
- 1999-01-25 ES ES009900182A patent/ES2147163B1/es not_active Expired - Fee Related
-
2000
- 2000-01-21 US US09/889,846 patent/US6706293B1/en not_active Expired - Fee Related
- 2000-01-21 JP JP2000594476A patent/JP2002535281A/ja not_active Withdrawn
- 2000-01-21 EP EP00901148A patent/EP1172111A1/en not_active Withdrawn
- 2000-01-21 WO PCT/ES2000/000026 patent/WO2000043023A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1172111A1 (en) | 2002-01-16 |
WO2000043023A1 (es) | 2000-07-27 |
US6706293B1 (en) | 2004-03-16 |
ES2147163A1 (es) | 2000-08-16 |
JP2002535281A (ja) | 2002-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0991407T3 (da) | Stabilisering af syresensitive benzimidazoler med amino/cyclodextrin-kombinationer | |
ES2138271T3 (es) | Compuestos de 6-dimetil-amino-metil-1-fenil-ciclohexano como principio activo farmaceutico. | |
DK1030670T3 (da) | Anvendelse af vitamin D-derivater til forstærkning af virkningen af cytotoksiske midler | |
ES2156603T3 (es) | Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina. | |
AR026610A1 (es) | Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central | |
PA8435001A1 (es) | Derivados 6,6-heterobiciclicos sustituidos. | |
DK0762896T3 (da) | Tocopherol-sammensætninger til levering af biologisk aktive stoffer | |
GT199800136A (es) | Formas de dosificacion farmaceuticas solidas. | |
BR9611802A (pt) | Composições farmacêuticas | |
ES2147163B1 (es) | Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion. | |
ME00298B (me) | Farmaceutski preparat | |
ATE509616T1 (de) | Topische pharmazeutische und/oder cosmetische dosierungssysteme | |
NO953278L (no) | Fremgangsmåter for in vivo-levering av biologisk aktive stoffer og sammensetninger som er nyttige for dette | |
ES2190692B1 (es) | Formulacion farmaceutica de amoxicilina y clavulanato de potasio. | |
DK1259240T3 (da) | Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme | |
ATE212351T1 (de) | Androsten-derivate | |
AR032293A1 (es) | Estuche farmaceutico | |
DE60019334D1 (de) | Antivirale arznei | |
DE69923336D1 (de) | Oral anzuwendende buprenorphinhaltige arzneimittel | |
NO993066L (no) | Ny behandling for leddinflammasjon | |
DE60102590D1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
AR025060A1 (es) | Formulaciones farmaceuticas en capsulas de hidroxipropilmetilcelulosa | |
PT1150704E (pt) | Melagatran para o tratamento da inflamacao | |
ES2172558T3 (es) | Lubricante compatible con radiaciones para dispositivos medicos. | |
ATE158172T1 (de) | Pulverförmige pharmazeutische zusammensetzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20000816 Kind code of ref document: A1 Effective date: 20000816 |
|
FD1A | Patent lapsed |
Effective date: 20101018 |